Market Context · Healthcare

Healthcare & Pharma Stocks

Map the listed companies behind established medicines, biotechnology platforms, genetic therapies and the research-to-market pathway.

3 subsectors · Pipeline exposure
Company index

Explore the healthcare innovation chain

Search by company or ticker, or narrow the directory to one part of the sector.

11 of 11 companies shown


01

Large Pharmaceutical Companies

5 companies

Established pharmaceutical firms are tracked for their broad product portfolios, global distribution networks, and ongoing investment in research, development, and lifecycle management.

02

Biotechnology & Specialty Therapeutics

3 companies

Biotechnology companies are followed for their focus on targeted therapies, genetic medicine, and biologics, where outcomes depend on research progress, clinical development, and regulatory review.

03

Genetic Medicine & Advanced Therapies

3 companies

Companies in genetic medicine and advanced therapeutics are tracked for their work on gene editing, cell therapies, and novel treatment platforms that target disease at the molecular level.

Sector orientation

What this market context covers

Healthcare and pharmaceutical companies operate across drug development, manufacturing, and distribution, supplying treatments, therapies, and medical products used by patients and healthcare systems worldwide.

This sector is commonly followed for exposure to research pipelines, regulatory processes, patent lifecycles, and demand driven by demographics, disease prevalence, and healthcare spending patterns.

Market context and company classification—not a ranking, recommendation or price target.
Reviewed by Andreas Torgersen · Editorial standards